GSA Capital Partners’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-56,673
| Closed | -$341K | – | 1397 |
|
|
2021
Q4 | $341K | Sell |
56,673
-11,532
| -17% | -$69.4K | 0.04% | 851 |
|
|
2021
Q3 | $604K | Buy |
68,205
+21,108
| +45% | +$187K | 0.06% | 585 |
|
|
2021
Q2 | $373K | Buy |
47,097
+8,091
| +21% | +$64.1K | 0.04% | 807 |
|
|
2021
Q1 | $297K | Buy |
+39,006
| New | +$297K | 0.05% | 652 |
|
|
2020
Q4 | – | Sell |
-13,823
| Closed | -$134K | – | 1197 |
|
|
2020
Q3 | $134K | Buy |
+13,823
| New | +$134K | 0.02% | 1087 |
|
|
2016
Q3 | – | Sell |
-4,647
| Closed | -$247K | – | 1758 |
|
|
2016
Q2 | $247K | Buy |
+4,647
| New | +$247K | 0.01% | 1484 |
|